TW200738665A - Nonsteroidal progesterone receptor modulators - Google Patents

Nonsteroidal progesterone receptor modulators

Info

Publication number
TW200738665A
TW200738665A TW095122741A TW95122741A TW200738665A TW 200738665 A TW200738665 A TW 200738665A TW 095122741 A TW095122741 A TW 095122741A TW 95122741 A TW95122741 A TW 95122741A TW 200738665 A TW200738665 A TW 200738665A
Authority
TW
Taiwan
Prior art keywords
receptor modulators
progesterone receptor
well
therapy
prophylaxis
Prior art date
Application number
TW095122741A
Other languages
English (en)
Chinese (zh)
Inventor
Ulrich Bothe
Ulrike Fuhrmann
Carsten Moller
Norbert Schmees
Anja Schmidt
Wolfgang Schwede
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of TW200738665A publication Critical patent/TW200738665A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
TW095122741A 2005-06-24 2006-06-23 Nonsteroidal progesterone receptor modulators TW200738665A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030294A DE102005030294A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
TW200738665A true TW200738665A (en) 2007-10-16

Family

ID=36716643

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095122741A TW200738665A (en) 2005-06-24 2006-06-23 Nonsteroidal progesterone receptor modulators

Country Status (22)

Country Link
EP (1) EP1899315A1 (ru)
JP (1) JP2008543911A (ru)
KR (1) KR20080018275A (ru)
CN (1) CN101248056A (ru)
AR (1) AR057409A1 (ru)
AU (1) AU2006261049A1 (ru)
BR (1) BRPI0612305A2 (ru)
CA (1) CA2611900A1 (ru)
CR (1) CR9595A (ru)
DE (1) DE102005030294A1 (ru)
DO (1) DOP2006000150A (ru)
EA (1) EA200702604A1 (ru)
EC (1) ECSP078043A (ru)
GT (1) GT200600272A (ru)
IL (1) IL188022A0 (ru)
MX (1) MX2008000070A (ru)
NO (1) NO20080441L (ru)
PE (1) PE20070170A1 (ru)
TW (1) TW200738665A (ru)
UY (1) UY29626A1 (ru)
WO (1) WO2006136462A1 (ru)
ZA (1) ZA200800689B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
TWI477276B (zh) * 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
ES2701400T3 (es) 2012-05-31 2019-02-22 Repros Therapeutics Inc Formulaciones para la administración vaginal de antiprogestinas
JP6343619B2 (ja) 2012-11-02 2018-06-13 レプロス セラピューティクス インコーポレイティド プロゲステロン依存性病態を処置する方法およびその組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
WO2000066590A2 (en) * 1999-05-04 2000-11-09 Ligand Pharmaceuticals, Inc. Tetracyclic progesterone receptor modulator compounds and methods
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
CA2472746A1 (en) * 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
ES2280766T3 (es) * 2002-03-11 2007-09-16 Bayer Schering Pharma Aktiengesellschaft 5-(2-hidroxi-3'-1-(3-trifluorometilfenil)-ciclopropil)-propionilamino)-ftalida y compuestos afines con actividad moduladora del receptor de progesterona, para uso en control de la fertilidad y terapia de reemplazamiento hormonal.
DE10346939A1 (de) * 2003-10-06 2005-05-19 Schering Ag Heterocyclisch substituierte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Also Published As

Publication number Publication date
DOP2006000150A (es) 2006-12-31
EP1899315A1 (en) 2008-03-19
JP2008543911A (ja) 2008-12-04
NO20080441L (no) 2008-03-07
DE102005030294A1 (de) 2007-01-04
PE20070170A1 (es) 2007-03-02
MX2008000070A (es) 2008-03-19
CR9595A (es) 2008-05-05
GT200600272A (es) 2007-08-20
KR20080018275A (ko) 2008-02-27
CN101248056A (zh) 2008-08-20
IL188022A0 (en) 2008-03-20
AR057409A1 (es) 2007-12-05
BRPI0612305A2 (pt) 2010-11-03
ECSP078043A (es) 2008-01-23
AU2006261049A1 (en) 2006-12-28
WO2006136462A1 (en) 2006-12-28
UY29626A1 (es) 2007-01-31
CA2611900A1 (en) 2006-12-28
EA200702604A1 (ru) 2008-06-30
ZA200800689B (en) 2009-07-29

Similar Documents

Publication Publication Date Title
MX338217B (es) Derivados de 17-hidroxi-17-pentafluoroetil-estra-4,9(10)-dien-11-a rilo, procedimientos para su preparacion y su uso para el tratamiento de enfermedades.
WO2011009530A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9 (10)-dien-11-acyloxyalkylenphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
TW200738665A (en) Nonsteroidal progesterone receptor modulators
UA98138C2 (ru) Производные бензамида как модуляторы фолликулостимулирующего гормона
WO2011009529A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
IL176738A0 (en) Selective estrogen receptor modulators for the treatment of vasomotor symptoms
MX2009009581A (es) Indazoles usados para tratar trastornos mediados por el receptor de estrogenos beta.
CU20120175A7 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
WO2011098437A3 (de) Progesteronrezeptorantagonisten
MX2009003981A (es) Agentes moduladores del receptor de calcio.
DK2018170T3 (da) Lægemiddel mod brystcancer
EA201491096A1 (ru) Производные 6,7-дигидро-5h-бензо[7]аннулена, способ их получения, фармацевтические препараты, которые их содержат, а также их применение для изготовления лекарственных средств
WO2011009534A3 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
MY183111A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
TW200740778A (en) Non-steroidal progesterone receptor modulators
DOP2006000147A (es) Uso de modulares no esteroides de receptores de progesterona.
UA92500C2 (ru) Цианопирролсульфонамидные модуляторы прогестеронового рецептора и их применение
HRP20110780T1 (en) Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention
WO2008113851A3 (en) Novel c11 modified retrosteroids as progesterone receptor modulator compounds
WO2008077647A3 (de) Alpha-aminoalkohole als nichtsteroidale progesteronrezeptor-modulatoren
TN2010000007A1 (en) 8-beta- substituted estratrienes as selectively active estrogens
UY30815A1 (es) Moduladores no esteroidales del receptor de progesterona
TH85420B (th) การใช้สารปรับโพรเจสเตอโรนรีเซปเตอร์ชนิดนอน-สเตียรอยด์